From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +0.23% | -0.23% | +4.76% |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
02/05 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.76% | 107.41Cr | |
+5.34% | 1.28TCr | |
+12.50% | 962.33Cr | |
+9.66% | 563.53Cr | |
-0.50% | 556.49Cr | |
+6.41% | 522.74Cr | |
+17.95% | 463.02Cr | |
+18.80% | 452.99Cr | |
+2.81% | 406.96Cr | |
+6.26% | 394.18Cr |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.